| dbo:abstract
|
- Margaret A. Liu (born June 11, 1956) is a physician and researcher studying gene expression, immune responses, and vaccines. From 2015-2017, Liu served as President of the . She is currently a professor of microbiology and immunology at the University of California, San Francisco (UCSF) and a foreign adjunct professor at the Karolinska Institute in Stockholm, Sweden. Since June 7, 2017, she has been a director of Ipsen S.A. in France. She is a founder of the field of DNA-based vaccines, and studies both plasmid DNA and mRNA vaccine technologies. She was the first researcher to provide evidence that gene-based immunization could protect against infectious diseases such as influenza, tuberculosis, HPV, and HIV. In addition to her work with animal models, she was involved with the first trial of a gene-based influenza vaccine in humans. In 2002, Discover magazine recognized Liu as one of the 50 most important women in science. (en)
|
| rdfs:comment
|
- Margaret A. Liu (born June 11, 1956) is a physician and researcher studying gene expression, immune responses, and vaccines. From 2015-2017, Liu served as President of the . She is currently a professor of microbiology and immunology at the University of California, San Francisco (UCSF) and a foreign adjunct professor at the Karolinska Institute in Stockholm, Sweden. Since June 7, 2017, she has been a director of Ipsen S.A. in France. (en)
|
